A nosocomial outbreak of Serratia marcescens producing inducible Amp C-type beta-lactamase enzyme and carrying antimicrobial resistance genes within a class 1 integron

Journal of Hospital Infection

Volumn 56, Issue 1, 2004, Pages 29-36

  Bagattini, M ^a   Crispino, M ^a   Gentile, F ^a,b   Barretta, E ^a   Schiavone, D ^a   Boccia, M C ^a   Triassi, M ^a   Zarrilli, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

Author keywords

Amp C type beta lactamase; Class 1 integron; Nosocomial outbreak; S. marcescens

Indexed keywords

AMIKACIN; AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHEM DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SPECTINOMYCIN; STREPTOMYCIN; SULTAMICILLIN; TETRACYCLINE; TRANSFERASE; TRIMETHOPRIM; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ENZYME INDUCTION; EPIDEMIC; GENOTYPE; HOSPITAL INFECTION; HUMAN; INTEGRON; INTENSIVE CARE UNIT; ISOELECTRIC FOCUSING; ITALY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PULSED FIELD GEL ELECTROPHORESIS; SERRATIA MARCESCENS; UNIVERSITY HOSPITAL;

ADULT; BACTERIAL PROTEINS; BETA-LACTAMASES; CLONE CELLS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTEGRONS; INTENSIVE CARE UNITS; ITALY; MALE; SERRATIA INFECTIONS; SERRATIA MARCESCENS;

EID: 0348229014     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2003.07.004     Document Type: Article

References (21)

1. Hejazi A. Falkiner F.R. Serratia marcescens J Med Microbiol 46 1997 903-912
2. Hejazi A. Aucken H.M. Falkiner F.R. Epidemiology and susceptibility of Serratia marcescens in a large general hospital over an eight-year period J Hosp Infect 45 2000 42-46
3. Van der Vorm E.R. Woldring-Zwaan C. Source, carriers, and management of a Serratia marcescens outbreak on a pulmonary unit J Hosp Infect 52 2002 263-267
4. Villari P. Crispino M. Salvadori A. Scarcella A. Molecular epidemiology of an outbreak of Serratia marcescens in a neonatal intensive care unit Infect Control Hosp Epidemiol 22 2001 630-634
5. Assadian O. Berger A. Aspock C. Mustafa S. Kohlhauser C. Hirschl A.M. Nosocomial outbreak of Serratia marcescens in a neonatal intensive care unit Infect Control Hosp Epidemiol 23 2002 457-461
6. Fleisch F. Zimmermann-Baer U. Zbinden R. et al. Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit Clin Infect Dis 34 2002 767-773
7. Luzzaro F. Perilli M. Migliavacca R. et al. Repeated epidemics caused by extended-spectrum beta-lactamases-producing Serratia marcescens strains Eur J Clin Microbiol Infect Dis 17 1998 629-636
8. Troillet N. Carmeli Y. DeGirolami P. Samore M.H. Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients J Hosp Infect 42 1999 37-43
9. Gaynes R.P. Horan T.C. Surveillance of nosocomial infections In: Mayall C.G. editor, Hospital epidemiology and infection control 1996 1017-1031 Williams and Wilkins Baltimore, MD
10. Coudron P.E. Moland E. Sanders C.C. Occurrence and detection of extended-spectrum beta-lactamase in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find J Clin Microbiol 35 1997 2593-2597
11. Cormican M.G. Marshall S.A. Jones R.N. Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen J Clin Microbiol 34 1996 1880-1884
12. National Committee for Clinical Laboratory Standards (NCCLS) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: performance standards for antimicrobial disk susceptibility tests 6th ed Approved standards. NCCLS document M7-A4 2000
13. Matthew M. Harris A.M. Marshall N.J. Ross C.W. The use of analytical isoelectric focusing for detection and identification of β-lactamases J Gen Microbiol 88 1975 169-178
14. Levesque C. Piché L. Larose C. Roy P.H. PCR mapping of integrons reveals several novel combinations of resistance genes Antimicrob Agents Chemother 39 1995 185-191
15. Girlich D. Poirel L. Leelaporn A. et al. Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand J Clin Microbiol 39 2001 175-182
16. Koeleman J.G. Stoof J. van der Bijl M.W. Vanderbroucke-Grauls C.M.J.E. Savelkou P.H.M. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR J Clin Microbiol 39 2001 8-13
17. Essack S.Y. Hall L.M. Pillay D.G. McFadyen M.L. Livermore D.M. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob Agents Chemother 45 2001 88-95
18. Maguire A.J. Brown D.F. Gray J.J. Desselberger U. Rapid screening technique for class 1 integrons in Enterobacteriaceae and nonfermenting Gram-negative bacteria and its use in molecular epidemiology Antimicrob Agents Chemother 45 2001 1022-1029
19. Jones R.N. Important and emerging β-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes Diagn Microbiol Infect Dis 31 1998 461-466
20. Steward C.D. Rasheed J.K. Hubert S.K. et al. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods J Clin Microbiol 39 2001 2864-2872
21. Smith H. Tucker F. The effect of antibiotic therapy on the fecal excretion of Salmonella typhimurium by experimentally infected chickens J Hyg 57 1975 275-292